Elsevier
Elsevier is a scientific publishing and research intelligence platform for institutions and professionals.
Analyst Perspective
Elsevier is a Netherlands-headquartered scientific publishing and research information business within RELX Group plc. It sells access to proprietary journals, databases, analytics tools, clinical decision support products, education platforms and research workflow software. Its portfolio includes ScienceDirect for full-text scientific content, Scopus and SciVal for research analytics, Mendeley for reference management, and specialist products for clinical, chemistry and biomedical use cases. The business primarily monetises through institutional subscriptions, platform licensing and other recurring contracts with universities, libraries, hospitals, governments, pharmaceutical companies and corporate R&D teams. It also earns from open access publishing fees, pay-per-view content, education software, and smaller media-related revenue streams such as advertising, reprints and sponsored supplements across owned journal properties.
Analyst Signal Briefing
Updated: 2 Jul 2026Elsevier has prioritised digital workflow efficiencies by launching a streamlined author submission experience and establishing an Ebola Information Centre to provide free clinical resources. The organisation also released a global study identifying a gap in clinical AI adoption, specifically noting that nurses are frequently excluded from technological integration. Furthermore, Elsevier-supported research highlighted that two-thirds of policy-relevant science remains uncited, reinforcing the company’s focus on improving the visibility and impact of research data through its analytical tools and collaborative platforms.
Explorer Tier
Start exploring for free
Start with public company intelligence. Save companies, build your first watchlist, and unlock deeper strategic insights when you are ready.
- View public Company Profiles
- Save/watch companies
- Build your first Watchlist
- Access additional market signals
Key insights about Elsevier
Category Differentiation
Elsevier is a scientific publishing and research information company, not a general consumer media publisher or a standalone foundational AI model provider. It competes more directly with academic information groups such as Clarivate, Springer Nature and Wiley than with mainstream news publishers.
Elsevier: About
Elsevier combines proprietary content ownership with software and analytics distribution. It creates and licenses high-value scientific and medical content, then layers discovery, benchmarking, workflow and decision-support tools on top of that corpus. Revenue is driven mainly by recurring institutional agreements, with additional monetisation from author-side publishing charges, transactional access, education products and specialised media inventory tied to its journals.
How Elsevier Works & Monetises
Business model analysis and core revenue streams
Elsevier uses a hybrid recurring-revenue model led by subscription and licensing fees for content databases, analytics platforms and workflow software. It also charges article processing charges for open-access publishing, pay-per-view and content purchases for individual access, institutional SaaS subscriptions for education and clinical tools, and media-related fees for advertising, reprints and sponsored supplements.
Revenue Channels
Side-by-Side Comparisons
Compare Elsevier directly with top competitors
Products & Services in Categories
Verified structural categorizations from the graph
Elsevier: Key Competitors & Alternatives
- Analyze Profile →
Scientific publisher and research information platform group.
- Analyze Profile →
Research, library and IP workflow software and data provider.
- Analyze Profile →
Open access scientific publisher for journals, institutions, and researchers.
Recent Signals (Elsevier)
Elsevier launches Ebola Information Center with free clinical and research resources to support response to outbreak
Elsevier has launched an Ebola Information Center providing free clinical and research resources to support the response to the outbreak.
Read original sourceThe future we build could depend on research we don’t read
New research supported by Elsevier datasets suggests that roughly two-thirds of highly policy-relevant science may go uncited — not because it lacks quality, but because it remains invisible.
Read original sourceThe future we build could depend on research we don’t read
New research supported by Elsevier datasets suggests that roughly two-thirds of highly policy-relevant science may go uncited — not because it lacks quality, but because it remains invisible.
Read original sourceElsevier: Frequently Asked Questions
What is Elsevier?
Elsevier is a scientific publishing, research information and workflow software business within RELX, serving academic, clinical and R&D markets.
Who uses Elsevier?
Universities, libraries, researchers, hospitals, government agencies, pharmaceutical companies, educators and corporate R&D teams use its platforms and content.
How does Elsevier make money?
It mainly earns from institutional subscriptions and licences, plus open-access publishing fees, transactional content sales, software subscriptions and smaller media-related revenues.
Company Facts
- Founded
- 1880
- Headquarters
- Netherlands
- Core Segment
- Publisher & Media Owner
- Company Size
- >5,000
- Official Link
- elsevier.com